Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT01769885
Show Display Options
Rank Status Study
1 Withdrawn Tivozanib Before Surgery in Treating Patients With Localized Kidney Cancer
Conditions: Stage II Renal Cell Cancer;   Stage III Renal Cell Cancer
Interventions: Drug: tivozanib;   Procedure: therapeutic conventional surgery

Indicates status has not been verified in more than two years